Skip to main content

Advertisement

SpringerLink
Log in

The aging of the HIV epidemic

  • Published:
Current HIV/AIDS Reports Aims and scope Submit manuscript

Abstract

Since the advent of highly active antiretroviral therapy, life expectancies for persons with HIV infection are similar to those for unifected people. A growing proportion of HIV-infected individuals are now over the age of 50. We are also seeing an increase in the incidence of HIV infection in older adults. To meet the challenges of the ongoing HIV epidemic, prevention efforts should include a focus on older adults. Also, HIV care providers must address the many comorbidities that are common in the aging population. Additional research will clarify how the processes of aging and HIV infection overlap and interact. This review addresses many of these important considerations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Joyce GF, Goldman DP, Leibowitz AA, et al.: A socioeconomic profile of older adults with HIV. J Health Care Poor Underserved 2005, 16:19–28.

    Article  PubMed  Google Scholar 

  2. Williams E, Donnelly J: Older Americans and AIDS: some guidelines for prevention. Social Work 2002, 47:105–111.

    PubMed  Google Scholar 

  3. Justice AC, Landefield CS, Asch SM, et al.: Justification for a new cohort study of people aging with and without HIV infection. J Clin Epidemiol 2001, S4:S3–S8.

    Article  Google Scholar 

  4. Centers for Disease Control and Prevention: Epidemiology of HIV/AIDS—United States, 1981–2005. MMRW Morb Mortal Wkly Rep 2006, 55:589–592.

    Google Scholar 

  5. Ledergerber B: Epidemiology of HIV, including response to ART, in older populations [abstract 108]. Presented at the 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 3–6, 2008.

  6. Paul SM, Martin RM, Lu SE, Lin Y: Changing trends in human immunodeficiency virus and acquired immunodeficiency syndrome in the population aged 50 and older. J Am Geriatr Soc 2007, 55:1393–1397.

    Article  PubMed  Google Scholar 

  7. Giunta S. Is inflammaging an auto[innate]immunity subclinical syndrome? Immun Ageing 2006, 3:12.

    Article  PubMed  CAS  Google Scholar 

  8. Lindau ST, Schumm LP, Laumann EO, et al.: A study of sexuality and health among older adults in the United States. N Engl J Med 2007, 357:762–774.

    Article  PubMed  CAS  Google Scholar 

  9. Bosch RJ, Bennett K, Collier AC, et al.: Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy. J Acquir Immune Defic Syndr 2007, 44:268–277.

    Article  PubMed  Google Scholar 

  10. Silverberg MJ, Leyden W, Horberg MA, et al.: Older age and the response to and tolerability of antiretroviral therapy. Arch Intern Med 2007, 167:684–691.

    Article  PubMed  CAS  Google Scholar 

  11. Sabin C; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study: Response to combination ART: variation by age [abstract 528]. Presented at the 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, CA; February 25–28, 2007.

  12. Onen NF, Presti R, Overton ET, et al.: Immune discordance on highly active antiretroviral therapy can still be regarded as a therapeutic success [abstract 952]. Presented at the 45th annual meeting of the Infectious Diseases Society of America. San Diego, CA; October 4–7, 2007.

  13. Müller V, Ledergerber B, Perrin L, et al.: Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS 2006, 20:889–894.

    PubMed  Google Scholar 

  14. Patterson K, Napravnik S, Eron J, et al.: Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy. HIV Med 2007, 8:406–410.

    Article  PubMed  CAS  Google Scholar 

  15. Cuzin L, Delpierre C, Gerard S, et al.: Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged > 50 years. Clin Infect Dis 2007, 45:654–657.

    Article  PubMed  Google Scholar 

  16. Gandhi RT, Spritzler J, Chan E, et al.: Effect of baseline-and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384. J Acquir Immune Defic Syndr 2006, 42:426–434.

    Article  PubMed  CAS  Google Scholar 

  17. Bestilny LJ, Gill MJ, Mody CH, Riabowol KT: Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS 2000, 14:771–780.

    Article  PubMed  CAS  Google Scholar 

  18. Douek DC, McFarland RD, Keiser PH, et al.: Changes in thymic function with age and during the treatment of HIV infection. Nature 1998, 396:690–695.

    Article  PubMed  CAS  Google Scholar 

  19. Ho Tsong Fang R, Colantonio AD, Uittenbogaart CH: The role of the thymus in HIV infection: a 10 year perspective. AIDS 2008, 22:171–184.

    PubMed  Google Scholar 

  20. Overton ET, Mondy K, Bush T, et al.: Factors associated with low bone mineral density in a large cohort of HIV-infected US adults: baseline results from the SUN study [abstract 836]. Presented at the 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, CA; February 25–28, 2007.

  21. Arnsten JH, Freeman R, Howard AA, et al.: Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 2007, 21:617–623.

    Article  PubMed  Google Scholar 

  22. Gallant JE, Staszewski S, Pozniak AL, et al.: Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA 2004, 292:191–201.

    Article  PubMed  CAS  Google Scholar 

  23. Tebas P, Umbleja T, Dubé M, et al.: Initiation of ART is associated with bone loss independent of the specific ART regimen. The results of ACTG A5005s [abstract 837]. Presented at the 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, CA; February 25–28, 2007.

  24. Mondy K, Powderly WG, Claxton SA, et al.: Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. J Acquir Immune Defic Syndr 2005, 38:426–431.

    Article  PubMed  CAS  Google Scholar 

  25. McComsey GA, Kendall MA, Tebas P, et al.: Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS 2007, 21:2473–2482.

    Article  PubMed  CAS  Google Scholar 

  26. Guaraldi G, Orlando G, Squillace N, et al.: Prevalence of secondary causes of osteoporosis among HIV-infected individuals. Antiviral Therapy 2006, 11:L9.

    Google Scholar 

  27. DAD Study Group; Friis-Møller N, Reiss P, et al.: Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 2007, 356:1723–1735.

    Article  PubMed  Google Scholar 

  28. Bozzette SA, Ake CF, Tam HK, et al.: Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2008, 47:338–341.

    PubMed  CAS  Google Scholar 

  29. Strategies for Management of Antiretroviral Therapy (SMART) Study Group; El-Sadr WM, Lundgren JD, et al.: CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 2006, 355:2283–2296.

    Article  PubMed  CAS  Google Scholar 

  30. Lichtenstein K, Armon C, Buchacz K, et al.: Analysis of cardiovascular risk factors in the HIV Outpatient Study Cohort [abstract 735]. Presented at the 13th Conference on Retroviruses and Opportunistic Infections. Denver, CO; February 5–8, 2006.

  31. Grundy SM: Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007, 92:399–404.

    Article  PubMed  CAS  Google Scholar 

  32. Mondy K, Overton ET, Grubb J, et al.: Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis 2007, 44:726–734.

    Article  PubMed  Google Scholar 

  33. Bonfanti P, Giannattasio C, Ricci E, et al.: HIV and metabolic syndrome: a comparison with the general population. J Acquir Immune Defic Syndr 2007, 45:426–431.

    Article  PubMed  Google Scholar 

  34. Wand H, Calmy A, Carey DL, et al.: Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection. AIDS 2007, 21:2445–2453.

    PubMed  CAS  Google Scholar 

  35. Monforte AD, Abrams D, Pradier C, et al.: HIV-induced immunodeficiency and risk of fatal AIDS-defining and non-AIDS-defining malignancies: results from the D:A:D Study [abstract 84]. Presented at the 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles, CA; February 25–28, 2007.

  36. Burgi A, Brodine S, Wegner S, et al.: Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 2005, 104:1505–1511.

    Article  PubMed  Google Scholar 

  37. Maurer T, Ponte M, Leslie K: HIV-associated Kaposi’s sarcoma with a high CD4 count and a low viral load. N Engl J Med 2007, 357:1352–1353.

    Article  PubMed  CAS  Google Scholar 

  38. Patel P, Hanson D, Novak RM, et al.: Trends in cancer incidence among HIV-infected persons in the United States in the HAART era [abstract 813]. Presented at the 4th International AIDS Society Conference. Sydney, Australia; July 22–25, 2007.

  39. Piketty C, Selinger-Leneman H, Grabar S, et al.: Dramatic increase in the incidence of anal cancer despite HAART in the French hospital database of HIV [abstract TUAB0305]. Presented at the XVI International AIDS Conference. Toronto, Canada; August 13–16, 2006.

  40. Conley L, Bush T, Darragh T, et al.: Incidence and predictors of anal squamous intraepithelial lesions in the SUN Study after 1 year of follow-up [abstract 1022. Presented at the 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA: February 3–6, 2008.

  41. Janssen RS, Nwanyanwu OC, Selik RM, Stehr-Green JK: Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology 1992, 42:1472–1476.

    PubMed  CAS  Google Scholar 

  42. Cherner M, Ellis RJ, Lazzaretto D, et al.: Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. AIDS 2004, 18(Suppl 1):S27–S34.

    PubMed  Google Scholar 

  43. Valcour VG, Sacktor NC, Paul RH, et al.: Insulin resistance is associated with cognition among HIV-1-infected patients: the Hawaii Aging With HIV cohort. J Acquir Immune Defic Syndr 2006, 43:405–410.

    Article  PubMed  Google Scholar 

  44. Bortz WM: A conceptual framework of frailty: a review. J Gerontol A Biol Sci Med Sci 2002, 57:M283–M288.

    PubMed  Google Scholar 

  45. Desquilbet L, Jacobson LP, Fried LP, et al.: HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci 2007, 62:1279–1286.

    PubMed  Google Scholar 

  46. Breen EC, Rezai AR, Nakajima K, et al.: Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990, 144:480–484.

    PubMed  CAS  Google Scholar 

  47. Leng S, Chaves P, Koenig K, Walston J: Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J Am Geriatr Soc 2002, 50:1268–1271.

    Article  PubMed  Google Scholar 

  48. Effros RB: Immune exhaustion in aging and AIDS: parallel mechanisms and possible solutions [abstract 105]. Presented at the 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 3–6, 2008.

  49. Tsangari H, Findlay DM, Kuliwaba JS, et al.: Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. Bone 2004, 35:334–342.

    Article  PubMed  CAS  Google Scholar 

  50. Shippy RA, Karpiak SE: The aging HIV/AIDS population: fragile social networks. Aging Ment Health 2005, 9:246–254.

    Article  PubMed  CAS  Google Scholar 

  51. Kalichman SC, Heckman T, Kochman A, et al.: Depression and thoughts of suicide among middle-aged and older persons living with HIV-AIDS. Psychiatr Serv 2001, 51:903–907.

    Article  Google Scholar 

  52. Chesney MA, Chambers DB, Taylor JM, Johnson LM: Social support, distress, and well-being in older men living with HIV infection. J Acquir Immune Defic Syndr 2003, 33:S185–S193.

    PubMed  Google Scholar 

  53. Emlet CA: “You’re awfully old to have this disease”: experiences of stigma and ageism in adults 50 years and older living with HIV/AIDS. Gerontologist 2006, 46:781–790.

    PubMed  Google Scholar 

  54. Emlet CA: A comparison of HIV stigma and disclosure patterns between older and younger adults living with HIV/AIDS. AIDS Patient Care STDS 2006, 20:350–358.

    Article  PubMed  Google Scholar 

  55. Branson BM, Handsfield HH, Lampe MA, et al.: Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006, 55:1–17.

    PubMed  Google Scholar 

  56. Raw M, McNeill A, West R: Smoking cessation guidelines for health professionals. A guide to effective smoking cessation interventions for the health care system. Thorax 1998, 53(Suppl 5):S1–S19.

    Article  Google Scholar 

  57. National Osteoporosis Foundation: Clinicians Guide to Prevention and Treatment of Osteoporosis. Available at http://www.nof.org/professionals/Clinicians_Guide.htm. Accessed April 30, 2008.

  58. Dube MP, Stein JH, Aberg JA, et al.: Guidelines for the evaluation and management of dyslipidemia in HIV infected adults receiving antiretroviral therapy. Clin Infect Dis 2003, 37:613–627.

    Article  PubMed  Google Scholar 

  59. US Preventive Services Task Force: Guide to Clinical Preventive Services, edn 3. Available at http://www.ahrq.gov/clinic/uspstfix.htm. Accessed May 22, 2008.

  60. Centers for Disease Control and Prevention; Workowski KA, Berman SM: Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006, 55:1–94.

    PubMed  Google Scholar 

  61. National Comprehensive Cancer Network: Clinical Practice Guidelines in Oncology. Prostate Cancer Early Detection. Available at http://www.nccn.org/professionals/physician_gls/PDF/prostate_detection.pdf. Accessed May 1, 2008.

  62. Levin B, Liberman DA, McFarland B, et al.: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008 Mar 5 (Epub ahead of print).

  63. Palefsky J: HPV infection in HIV infected persons. Top HIV Med 2007, 15:130–133.

    PubMed  Google Scholar 

  64. American Cancer Society: Skin Cancer Prevention and Early Detection. Available at http://www.cancer.org/docroot/PED/content/ped_7_1_Skin_Cancer_Detection_What_You_Can_Do.asp. Accessed May 1, 2008.

  65. American Association for the Study of Liver Diseases: Practice Guidelines-Viral Hepatitis. Available at https://www.aasld.org/eweb/DynamicPage.aspx?Site=AASLD3&webcode=viral Hepatitis. Accessed May 1, 2008.

  66. Recommended adult immunization schedule: United States, October 2007–September 2008. Ann Intern Med 2007, 147:725–729.

    Google Scholar 

  67. Smith RA, Saslow D, Sawyer KA, et al.: American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003, 53:141–169.

    Article  PubMed  Google Scholar 

  68. Sacktor NC, Wong M, Nakasujja N, et al.: The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 2005, 19:1367–1374.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Washington University School of Medicine, 660 South Euclid, Campus Box 8051, St. Louis, MO, 63110, USA

    Edgar Turner Overton

Authors
  1. Kavita P. Bhavan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinay N. Kampalath
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Edgar Turner Overton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Edgar Turner Overton.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhavan, K.P., Kampalath, V.N. & Overton, E.T. The aging of the HIV epidemic. Curr HIV/AIDS Rep 5, 150–158 (2008). https://doi.org/10.1007/s11904-008-0023-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11904-008-0023-3

Keywords

Search

Navigation